Modern Pediatrics. Ukraine. (2023). 7(135): 33-37. doi: 10.15574/SP.2023.135.33
Shadrin O. G. ¹, Mostovenko R. V.², Horіanska M. H.¹, Marushko T. L.¹, Kovalchuk A. A.^1
1SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv
²National Children’s Specialized Hospital «OKHMATDYT», Kyiv, Ukraine

For citation: Shadrin OG, Mostovenko RV, Horіanska MH, Marushko TL, Kovalchuk AA. (2023). Risk factors of inflammatory bowel diseases in young children. Modern Pediatrics. Ukraine. 7(135): 33-37. doi: 10.15574/SP.2023.135.33.
Article received: Jul 14, 2023. Accepted for publication: Nov 18, 2023.

In recent decades, there has been a rapid increase in the incidence of inflammatory bowel diseases in the children's population, especially in the age group under 6 years old. Risk factors significantly affect the reactive response of the child's organism and the probability of a pathology occurrence.
Purpose – to analyze risk factors for the development of inflammatory bowel diseases with very early onset in children.
Materials and methods. The anamnestic data of 78 examined patients with inflammatory bowel diseases – 17 patients with inflammatory bowel diseases with a very early onset and 61 children with inflammatory bowel disease that debuted over 6 years of age – were studied in detail retrospectively.
Results. The anamnestic risk factors that were significantly more often observed in patients with inflammatory bowel diseases with a very early onset compared to children with inflammatory bowel diseases with an onset after 6 years of age included: spontaneous abortion in patients' mothers anamnesis, autoimmune diseases in relatives, the presence of concomitant autoimmune diseases in patients, early introduction of artificial feeding and the presence of an infectious disease just before the onset of inflammatory bowel disease.
Conclusions. Taking into account the identified risk factors of inflammatory bowel diseases with a very early onset will ensure the improvement of prevention and early diagnosis of this gastrointestinal disease in young children.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the institution mentioned in the work. The informed consent of the children’s parents was obtained for the conducting the studies.
No conflict of interests was declared by the authors.
Keywords: inflammatory bowel disease, children, risk factor, early age, war.

REFERENCES

1. Aloi M, Lionetti P, Barabino A, Guariso G et al. (2014). Phenotype and disease course of early-onset pediatric inflammatory bowel disease. Inflamm Bowel Dis. 20(4): 597-605. https://doi.org/10.1097/01.MIB.0000442921.77945.09; PMid:24569242

2. Ananthakrishnan AN, Higuchi LM, Huang ES et al. (2012). Aspirin, nonsteroidal anti-inflammatory drug use and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med. 156: 350. https://doi.org/10.7326/0003-4819-156-5-201203060-00007; PMid:22393130 PMCid:PMC3369539

3. Baumgart DC, Carding SR. (2007). Inflammatory bowel disease: cause and immunobiology. Lancet. 369: 1627-1640. https://doi.org/10.1016/S0140-6736(07)60750-8; PMid:17499605

4. Benchimol E, Fortinsky K, Gozdyra P, Van den Heuvel M et al. (2011). Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends. Inflamm Bowel Dis. 17(1): 423-439. https://doi.org/10.1002/ibd.21349; PMid:20564651

5. Benchimol EI, Bernstein CN, Bitton A, Carroll MW et al. (2017). Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases. Am J Gastroenterol. 112(7): 1120-1134. https://doi.org/10.1038/ajg.2017.97; PMid:28417994 PMCid:PMC5527278

6. Bequet E, Sarter H, Fumery M, Vasseur F et al. (2017). Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]. J Crohns Colitis. 11(5): 519-526.

7. Capriati T, Cardile S, Papadatou B, Romano C, Knafelz D, Bracci F, Diamanti A. (2016). Pediatric inflammatory bowel disease: specificity of very early onset. Expert Rev Clin Immunol. 12(9): 963-972. https://doi.org/10.1080/1744666X.2016.1184571; PMid:27247160

8. Davis MK. (2001). Breastfeeding and chronic disease in childhood and adolescence. Pediatr Clin North Am. 48: 125. https://doi.org/10.1016/S0031-3955(05)70289-3; PMid:11236720

9. Duricova D, Burisch J, Jess T, Gower-Rousseau C et al. (2014). Age-related differences in presentation and cource of inflammatory bowel disease: An update on the population-based literature. J Crohn's Colitis. 8(11): 1351-1361. https://doi.org/10.1016/j.crohns.2014.05.006; PMid:24951261

10. Glassman MS, Newman LJ, Berezin S, Gryboski JD. (1990). Cow's milk protein sensitivity during infancy in patients with inflammatory bowel disease. Am J Gastroenterol. 85: 838.

11. Gradel KO, Nielsen HL, Schønheyder HC, Ejlertsen T, Kristensen B, Nielsen H. (2009). Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology. 137(2): 495-501. https://doi.org/10.1053/j.gastro.2009.04.001; PMid:19361507

12. Hwang S, Kim J, Im J, Ye B et al. (2017). Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study. J Gastroenterol Hepatol. 32(10): 1716-1722. https://doi.org/10.1111/jgh.13775; PMid:28251684

13. Kappelman MD, Rifas-Shiman SL, Kleinman K et al. (2007). The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 5: 1424. https://doi.org/10.1016/j.cgh.2007.07.012; PMid:17904915

14. Kelsen JR, Sullivan KE, Rabizadeh S, Singh N, Snapper S, Elkadri A, Grossman AB. (2020). North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Evaluation and Management for Patients With Very Early-onset Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 70(3): 389-403. https://doi.org/10.1097/MPG.0000000000002567; PMid:32079889

15. Lerebours E, Gower-Rousseau C, Merle V, Brazier F, Debeugny S, Marti R et al. (2007). Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study. Am J Gastroenterol. 102(1): 122-131. https://doi.org/10.1111/j.1572-0241.2006.00931.x; PMid:17100973

16. Levine A, Koletzko S, Turner D, Escher J et al. (2014). The ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 58(6): 795-806. https://doi.org/10.1097/MPG.0000000000000239; PMid:24231644

17. Mamula P, Telega GW, Markowitz JE, Brown KA, Russo PA, Piccoli DA, Baldassano RN. (2002). Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol. 97(8): 2005-2010. https://doi.org/10.1111/j.1572-0241.2002.05915.x; PMid:12190168

18. Mirkov MU, Verstockt B, Cleynen I. (2017). Genetics of inflammatory bowel disease: beyond NOD2. Lancet Gastroenterol Hepatol. 2(3): 224-234. https://doi.org/10.1016/S2468-1253(16)30111-X; PMid:28404137

19. Mouzan MI, Saadah O, Al-Saleem K et al. (2014). Incidence of pediatric inflammatory bowel disease in Saudi Arabia: a multicenter national study. Inflamm Bowel Dis. 20(6): 1085-1090. https://doi.org/10.1097/MIB.0000000000000048; PMid:24788219

20. Porter CK, Tribble DR, Aliaga PA, Halvorson HA, Riddle MS. (2008). Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology. 135(3): 781-786. https://doi.org/10.1053/j.gastro.2008.05.081; PMid:18640117

21. Shadrin OH, Marushko RV, Briuzghina TS ta in. (2010). Funktsionalne kharchuvannia ta zapalni zakhvoriuvannia kyshechnyka u ditei rannoho viku. Sovremennaya pediatriya. 6(34): 82-86.

22. Shaw SY, Blanchard JF, Bernstein CN. (2011). Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol. 106(12): 2133-2142. https://doi.org/10.1038/ajg.2011.304; PMid:21912437

23. Singh S, Graff LA, Bernstein CN. (2009). Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol. 104(5): 1298-1313. https://doi.org/10.1038/ajg.2009.15; PMid:19337242

24. Sýkora J, Pomahačová R, Kreslová M, Cvalínová D, Štych P, Schwarz J. (2018). Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol. 24(25): 2741-2763. https://doi.org/10.3748/wjg.v24.i25.2741; PMid:29991879 PMCid:PMC6034144

25. Uhlig HH, Charbit-Henrion F, Kotlarz D et al. (2021). Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 72(3): 456-473. https://doi.org/10.1097/MPG.0000000000003017; PMid:33346580 PMCid:PMC8221730

26. Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, Ouahed J, Wilson DC, Travis SP, Turner D, Klein C, Snapper SB, Muise AM; COLORS in IBD Study Group and NEOPICS. (2014). The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 147(5): 990-1007. https://doi.org/10.1053/j.gastro.2014.07.023; PMid:25058236 PMCid:PMC5376484